Dawn Svoronos insider trades: Xenon Pharmaceuticals (XENE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dawn reports to the SEC
and 1 more company
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 24, 2023 | XENE | ↓ Sell | 25,000 | $38.70 | $968K | Direct | Aug 24, 2023 (0d) |
| May 9, 2023 | SLRN | ↑ Buy | 15,000 | $18.00 | $270K | Direct | May 11, 2023 (2d) |
| Jun 21, 2022 | GBT | ↓ Sell | 1,908 | $27.24 | $52K | Direct | Jun 22, 2022 (1d) |
| Jun 9, 2022 | PTCT | ↓ Sell | 738 | $27.20 | $20K | Direct | Jun 10, 2022 (1d) |
| May 16, 2022 | ADVM | ↑ Buy | 30,000 | $0.85 | $26K | Direct | May 18, 2022 (2d) |
| Jan 7, 2022 | PTCT | ↓ Sell | 510 | $38.52 | $20K | Direct | Jan 11, 2022 (4d) |
| Jun 18, 2021 | GBT | ↓ Sell | 1,609 | $36.54 | $59K | Direct | Jun 21, 2021 (3d) |
| Jun 9, 2021 | PTCT | ↓ Sell | 365 | $41.88 | $15K | Direct | Jun 11, 2021 (2d) |
| Mar 31, 2021 | ADVM | ↑ Buy | 20,000 | $10.02 | $200K | Direct | Apr 1, 2021 (1d) |
| Feb 1, 2021 | PTCT | ↓ Sell | 506 | $56.96 | $29K | Direct | Feb 2, 2021 (1d) |
| Jun 19, 2020 | GBT | ↓ Sell10b5-1 | 2,544 | $63.94 | $163K | Direct | Jun 19, 2020 (0d) |
| Jun 11, 2020 | PTCT | ↓ Sell | 364 | $48.36 | $18K | Direct | Jun 12, 2020 (1d) |
| Aug 14, 2017 | XENE | ↑ Buy | 50,000 | $2.82 | $141K | Direct | Aug 15, 2017 (1d) |
| May 23, 2017 | PTCT | ↑ Buy | 25,000 | $13.49 | $337K | Direct | May 24, 2017 (1d) |
| Mar 14, 2016 | MDVN | ↓ Sell | 6,000 | $38.90 | $233K | Direct | Mar 16, 2016 (2d) |
| Sep 8, 2015 | MDVN | ↓ Sell10b5-1 | 3,100 | $89.15 | $276K | Direct | Sep 8, 2015 (0d) |
| Mar 2, 2015 | MDVN | ↓ Sell | 3,350 | $119.75 | $401K | Direct | Mar 4, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other XENE insiders
Open-market trades in the last 12 months
About Dawn Svoronos's insider trades
Dawn Svoronos is an insider at Xenon Pharmaceuticals (XENE). Since Mar 2, 2015, Dawn has reported 5 open-market purchases worth $974K and 12 sales worth $2.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
2 sales (19% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (39 filings), option exercises (5 filings), shares returned to the company (5 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XENE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.